GSK

Showing 15 posts of 760 posts found.

Former Novartis man becomes GSK’s new medical director

May 8, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Shannon, Novartis

James Shannon has been named GSK’s chief medical officer, and will report to R&D chairman Moncef Slaoui.  He will be …

GSK picture

GSK signs deal with academics

May 4, 2012
Research and Development, Sales and Marketing Cancer, GSK, PROTAC, Yale, academia

GlaxoSmithKline has forged another link with academia, signing a deal with Yale University to design a potential new class of …

GSK appoints two non-executive directors to its Board

May 3, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Jing Ulrich, Lynn Elsenhans

GlaxoSmithKline has announced that Lynn Elsenhans and Jing Ulrich will join the Board of the Company with effect from 1 …

Votrient image

FDA approves GSK’s Votrient for new licence

April 30, 2012
Sales and Marketing Cancer, FDA Approval, GSK, Votrient

The FDA has approved GlaxoSmithKline’s cancer pill Votrient for the treatment of a rare group of cancers – but has …

Benlysta image

NICE no to GSK’s lupus drug Benlysta

April 27, 2012
Sales and Marketing Andrew Dillon, Benlysta, GSK, Lupus, NICE

NICE is still not recommending GlaxoSmithKline’s lupus drug Benlysta, as it believes the treatment is too costly.  In its final …

Novartis image

Novartis to invest $550m in new Swiss plant

April 24, 2012
Manufacturing and Production GSK, Novartis, manufacturing and production

Novartis has unveiled plans to build a new manufacturing facility at its site in Stein, Switzerland, just weeks after calling …

GSK

GSK’s bid for Human Genome Sciences rejected

April 19, 2012
Sales and Marketing Benlysta, GSK, Human Genome Sciences, mergers and acquisitions

GlaxoSmithKline has launched a takeover bid for Human Genome Sciences for around $2.5 billion, but has been rejected by the …

GSK image

GSK’s diabetes drug misses goal

April 4, 2012
Research and Development, Sales and Marketing Bydureon, GSK, Victoza, albiglutide, diabetes

GlaxoSmithKline has insisted its new long-acting Type 2 diabetes drug albiglutide remains on course for filing following topline results from …

Roche image

Roche to submit Herceptin successor to regulators

April 2, 2012
Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda

Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …

GSK image

GSK settles cancer patent dispute

March 28, 2012
Research and Development, Sales and Marketing GSK, Genmab, Roche, ofatumumab, patents

GlaxoSmithKline has settled a long-running patent dispute over its cancer treatment ofatumumab.  The US patents, which relate to recombinant antibody …

Early-stage research gains another funding boost

March 23, 2012
Research and Development, Sales and Marketing GSK, Index Ventures, Janssen, R&D

GlaxoSmithKline and Janssen are among the key investors in a venture capital fund aimed solely at identifying promising pharma start-ups.  …

GSK image

GSK selects Ulverston for biopharma manufacturing hub

March 22, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Cameron, GSK, Ulverston, manufacturing

GlaxoSmithKline has announced the long-awaited decision on the location of its biopharmaceutical plant in the UK, with Ulverston in Cumbria …

British biotech industry gains £200m boost

March 21, 2012
Research and Development, Sales and Marketing GSK, Wellcome Trust, biotech, fund

The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …

GSK sells off OTC products

March 16, 2012
Sales and Marketing GSK, OTC, Omega Pharma, Zantac

GlaxoSmithKline has shed more of its non-core consumer health OTC products in a £391 million sale, including a German manufacturing …

GSK chooses Infosys and Fabric Worldwide for digital platform

March 15, 2012
Medical Communications, Sales and Marketing Fabric Worldwide, GSK, Infosys, digital

GlaxoSmithKline has hired two technology companies to help it optimise digital communications in consumer healthcare and pharmaceuticals.The firm will work …

The Gateway to Local Adoption Series

Latest content